“…Alternatively, transgenic mice which express human major histocompatibility class II molecules have been engineered resulting in a more robust response to SEB (Faulkner et al, 2005; Rajagopalan et al, 2009). Larger animal models respond systemically to SEB as a superantigen (Krakauer et al, 2016), including swine (Bost et al, 2016; Hudson et al, 2013) and non-human primates (He et al, 2014; Komisar et al, 2001; Weng et al, 1997). These models have also been used to suggest efficacy of various SEB vaccination formulations (Boles et al, 2003; Hudson et al, 2013; Tseng et al, 1995).…”